Loading clinical trials...
Loading clinical trials...
EVEREST - IBD: Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease
To develop and train a convolutional neural network to detect and characterize disease severity of inflammatory bowel disease during endoscopy
To develop and train a Convolutional Neural Network to detect and characterize disease severity in inflammatory bowel disease during endoscopy. This initiative will inevitably establish a high-quality large image database. Our secondary study aims are therefore to use the images we collect to advance the field of deep learning and computer aided diagnosis in inflammatory bowel disease by establishing an image database. This will involve developing a framework combining deep learning and computer vision algorithms. The ultimate aim is to use the image database to produce high impact research outcomes and training resources leading to an improvement in the quality of endoscopy performed, reduce inter-observer variability in disease assessment and a reduction in missed bowel cancer rates and associated mortality.
Age
16 - 99 years
Sex
ALL
Healthy Volunteers
Yes
Hull Royal Infirmary
Hull, East Yorkshire, United Kingdom
Start Date
September 17, 2021
Primary Completion Date
September 1, 2031
Completion Date
September 1, 2031
Last Updated
November 15, 2024
4,000
ESTIMATED participants
Lead Sponsor
Hull University Teaching Hospitals NHS Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions